tryptophan has been researched along with Small Cell Lung Carcinoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Aojula, HS; Freeman, S; Haitham Abusara, O | 1 |
| Albanes, D; Alcala, K; Arslan, AA; Blot, WJ; Brennan, P; Buring, JE; Cai, Q; Caporaso, NE; Fanidi, A; Freedman, ND; Gao, YT; Gaziano, JM; Giles, GG; Grankvist, K; Haiman, CA; Han, J; Hodge, AM; Huang, JY; Hveem, K; Johansson, M; Koh, WP; Lan, Q; Langhammer, A; Larose, TL; Le Marchand, L; Lee, IM; Li, HL; Luu, HN; Manjer, J; Midttun, Ø; Pettinger, M; Prentice, RL; Purdue, MP; Relton, C; Sesso, HD; Severi, G; Shu, XO; Stampfer, MJ; Stevens, VL; Thomson, CA; Ueland, PM; Ulvi, A; Visvanathan, K; Wang, R; Weinstein, SJ; Wilkens, LR; Wu, J; Xiang, YB; Yuan, JM; Zeleniuch-Jacquotte, A; Zhang, X; Zheng, W; Ziegler, RG | 1 |
| Engin, AB; Fuchs, D; Ozkan, Y; Yardim-Akaydin, S | 1 |
3 other study(ies) available for tryptophan and Small Cell Lung Carcinoma
| Article | Year |
|---|---|
Pentapeptides for the treatment of small cell lung cancer: Optimisation by N
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Molecular Structure; Oligopeptides; Small Cell Lung Carcinoma; Structure-Activity Relationship; Tryptophan | 2017 |
Circulating markers of cellular immune activation in prediagnostic blood sample and lung cancer risk in the Lung Cancer Cohort Consortium (LC3).
Topics: Adenocarcinoma of Lung; Adult; Aged; Biomarkers, Tumor; Carcinoma, Large Cell; Carcinoma, Squamous Cell; Case-Control Studies; Female; Follow-Up Studies; Humans; Inflammation; Kynurenine; Lung Neoplasms; Male; Middle Aged; Neopterin; Prognosis; Prospective Studies; Risk Factors; Small Cell Lung Carcinoma; Tryptophan | 2020 |
Increased tryptophan degradation in patients with bronchus carcinoma.
Topics: Blood Sedimentation; C-Reactive Protein; Carcinoma, Non-Small-Cell Lung; Female; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Male; Middle Aged; Neoplasm Proteins; Neopterin; Pilot Projects; Small Cell Lung Carcinoma; Tryptophan | 2010 |